DNA methylation signatures in circulating cell-free DNA as biomarkers for the early detection of cancer (Q38773645)

6 September 2017

title

DNA methylation signatures in circulating cell-free DNA as biomarkers for the early detection of cancer (English)

1 reference

early detection of cancer

6 September 2017

0 references

0 references

1 reference

Junyun Wang

1

1 reference

6 September 2017

Xiao Han

series ordinal

2

1 reference

6 September 2017

Yingli Sun

series ordinal

3

1 reference

6 September 2017

publication date

5 January 2017

1 reference

Science in China. Series C: Life Sciences

6 September 2017

published in

1 reference

6 September 2017

volume

60

1 reference

6 September 2017

issue

4

1 reference

6 September 2017

page(s)

356-362

1 reference

Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

CpG island hypermethylation profile in the serum of men with clinically localized and hormone refractory metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Utility of MLH1 methylation analysis in the clinical evaluation of Lynch Syndrome in women with endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Methylation-specific sequencing of GSTP1 gene promoter in circulating/extracellular DNA from blood and urine of healthy donors and prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Analysis of circulating tumor DNA to monitor metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

CA 15-3: Uses and limitation as a biomarker for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

DNA methylation in cancer: three decades of discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Beyond the genome: epigenetic mechanisms in lung remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Development of a multiplex MethyLight assay for the detection of multigene methylation in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

The potential use of cell-free-circulating-tumor DNA as a biomarker for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Optimizing methodologies for PCR-based DNA methylation analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Multitarget stool DNA testing for colorectal-cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Epigenetics in asthma and COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Circulating DNA in solid organ cancers-analysis and clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

DNA Methylation Analysis: Choosing the Right Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

The power and the promise of DNA methylation markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Principles and challenges of genomewide DNA methylation analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Differential methylation of cell-free circulating DNA among patients with pancreatic cancer versus chronic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Hypermethylation of p16INK4a in Chinese lung cancer patients: biological and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Epigenomic alterations define lethal CIMP-positive ependymomas of infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Differential methylation profile of ovarian cancer in tissues and plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Measuring the methylome in clinical samples: improved processing of the Infinium Human Methylation450 BeadChip Array.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Methylation analysis of MLH1 improves the selection of patients for genetic testing in Lynch syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Characterization of DNA Methylation in Circulating Tumor Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Septin 9 promoter region methylation in free circulating DNA-potential role in noninvasive diagnosis of lung cancer: preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

14-3-3sigma methylation in pretreatment serum circulating DNA of cisplatin-plus-gemcitabine-treated advanced non-small-cell lung cancer patients predicts survival: The Spanish Lung Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

High concordance of gene methylation in post-digital rectal examination and post-biopsy urine samples for prostate cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Promoter hypermethylation in circulating blood cells identifies prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Extracellular DNA in breast cancer: Cell-surface-bound, tumor-derived extracellular DNA in blood of patients with breast cancer and nonmalignant tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Cell-free nucleic acids as biomarkers in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

CpG hypomethylation of MDR1 gene in tumor and serum of invasive ductal breast carcinoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

DNA methylation based biomarkers in non-invasive cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Aberrant DNA methylation of the p16INK4a gene in plasma DNA of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Large hypomethylated blocks as a universal defining epigenetic alteration in human solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Detection of aberrant promoter methylation of GSTP1 in the tumor and serum of Chinese human primary hepatocellular carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Methylated circulating tumor DNA in blood: power in cancer prognosis and response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Diagnostic Performance of Plasma DNA Methylation Profiles in Lung Cancer, Pulmonary Fibrosis and COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

Aberrant methylation of RASSF1A in plasma DNA before breast cancer diagnosis in the Breast Cancer Family Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0253-7

10.1007/S11427-016-0253-7

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

1053558061

0 references

1 reference